ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Cenexel Clinical Research, INC.

Official 2024 U.S. DOL Form 5500 summary for Cenexel Clinical Research, INC. (Cenexel Clinical Research, INC. 401(k) Plan · EIN 83-1353724 · PN 001): $13.59M net assets, 968 active participants, and $86.03 per $10,000 (86.03 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorCenexel Clinical Research, INC.
Filing IdentifierCenexel Clinical Research, INC. 401(k) Plan · EIN 83-1353724 · PN 001
Plan Category & State401(k) Defined Contribution (UT)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$13.59M
Active Participants968
Direct Admin Fee Rate$86.03 per $10,000 (86.03 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderPrincipal Financial Group
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI